Vifor Pharma To Pay NHS £23M Over Misinformation Probe
A global pharmaceutical has agreed to pay the National Health Service £23 million ($29.3 million) to address concerns it spread misinformation to healthcare professionals about the safety of a rival treatment...To view the full article, register now.
Already a subscriber? Click here to view full article